Ancora Advisors LLC lifted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.2% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 69,162 shares of the healthcare conglomerate’s stock after purchasing an additional 2,123 shares during the quarter. UnitedHealth Group accounts for about 0.8% of Ancora Advisors LLC’s investment portfolio, making the stock its 24th biggest holding. Ancora Advisors LLC’s holdings in UnitedHealth Group were worth $17,230,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also recently bought and sold shares of UNH. Martingale Asset Management L P raised its position in shares of UnitedHealth Group by 1.7% in the third quarter. Martingale Asset Management L P now owns 214,133 shares of the healthcare conglomerate’s stock valued at $56,969,000 after buying an additional 3,598 shares during the last quarter. Blue Fin Capital Inc. raised its position in shares of UnitedHealth Group by 7.2% in the third quarter. Blue Fin Capital Inc. now owns 10,689 shares of the healthcare conglomerate’s stock valued at $2,844,000 after buying an additional 722 shares during the last quarter. Kentucky Retirement Systems acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $6,259,000. Teachers Advisors LLC raised its position in shares of UnitedHealth Group by 11.2% in the third quarter. Teachers Advisors LLC now owns 1,704,624 shares of the healthcare conglomerate’s stock valued at $453,498,000 after buying an additional 171,478 shares during the last quarter. Finally, TIAA CREF Investment Management LLC raised its position in shares of UnitedHealth Group by 7.3% in the third quarter. TIAA CREF Investment Management LLC now owns 5,462,680 shares of the healthcare conglomerate’s stock valued at $1,453,291,000 after buying an additional 370,179 shares during the last quarter. 86.72% of the stock is owned by institutional investors.
Shares of UNH opened at $237.00 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94. The stock has a market capitalization of $225.68 billion, a P/E ratio of 18.40, a PEG ratio of 1.23 and a beta of 0.79.
UNH has been the subject of a number of recent research reports. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 19th. Bank of America reiterated a “buy” rating and issued a $290.00 target price (down from $320.00) on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Oppenheimer increased their target price on shares of UnitedHealth Group from $300.00 to $305.00 and gave the company an “outperform” rating in a research report on Wednesday, January 16th. Raymond James reduced their target price on shares of UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating for the company in a research report on Wednesday, April 17th. Finally, ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $288.74.
In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of the stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $257.32, for a total transaction of $1,286,600.00. Following the completion of the transaction, the director now owns 182,454 shares of the company’s stock, valued at $46,949,063.28. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the transaction, the director now directly owns 64,726 shares of the company’s stock, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. Insiders sold 22,930 shares of company stock valued at $5,551,583 in the last three months. 0.87% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Ancora Advisors LLC Purchases 2,123 Shares of UnitedHealth Group Inc (UNH)” was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/04/27/ancora-advisors-llc-purchases-2123-shares-of-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What are momentum indicators and what do they show?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.